Viral oncology advance

Reovirus is a common virus that causes mild cases of respiratory infection. However, it could be harnessed as an immunotherapy to fight primary liver cancer and hepatitis C. Researchers, including former Centre Clinical Research Fellow Dr Adel Samson and former Centre Director Prof. Alan Melcher, have shown that our immune systems can be coerced into targeting both liver cancer and the underlying hepatitis C virus infection that is driving it to grow. For more information, please see the engaging summary written by study author Dr Steve Griffin for the Conversation website. The original paper is open access and available from the Gut journal website.

Image credit: A 3D printed model of a reovirus by NIAID CC BY 2.0

« Go back

Page last updated: 16/11/2016